Top-News
  • Depot
  • Watchlist
  • Glocke
  • Handeln

    • Arcus Biosciences Inc. News

    15,63 $ 0,00% +0,00 $
    In : 14,603 € | 01:00:00 Uhr NYSE aktualisieren | Orderbuch | Mehr Kurse »
    WKN: A2JGDZ
    ISIN: US03969F1093
    US-Symbol: RCUS
    Typ: Aktie

    Arcus Biosciences Inc. News

    30.01.24 - PR Newswire
    Thinking about buying stock in Arcus Biosciences, Palatin Technologies, Exxon Mobil, Archer Aviation, or Sidus Space ?
    Thinking about buying stock in Arcus Biosciences, Palatin Technologies, Exxon Mobil, Archer Aviation, or Sidus Space ? PR Newswire
    01.12.22 - PR Newswire
    Optimism Building for Advancing Pancreatic Cancer Treatment Therapies
    Optimism Building for Advancing Pancreatic Cancer Treatment Therapies PR Newswire
    01.12.22 - PR Newswire
    Optimism Building for Advancing Pancreatic Cancer Treatment Therapies
    Optimism Building for Advancing Pancreatic Cancer Treatment Therapies PR Newswire
    30.11.22 - ESG-Aktien
    Fortschritte im Kampf gegen Krebs: Arcus Biosciences, Gilead Sciences, Defence Therapeutics, BioNTech
    Wie Untersuchungen aus dem Jahr 2020 zeigen, haben 72% der Deutschen Angst vor Krebs. Eingestehen mögen sich diese Ängste jedoch die Wenigsten. Doch gerade weil das ...
    04.04.22 - PR Newswire
    Arcus Biosciences Set to Join S&P SmallCap 600
    Arcus Biosciences Set to Join S&P SmallCap 600 PR Newswire
    17.09.21 - PR Newswire
    Thinking about buying stock in Corvus Pharmaceuticals, AbCellera Biologics, Rekor Systems, SmileDirectClub, or Arcus Biosciences?
    Thinking about buying stock in Corvus Pharmaceuticals, AbCellera Biologics, Rekor Systems, SmileDirectClub, or Arcus Biosciences? PR Newswire
    24.06.21 - PR Newswire
    Thinking about buying stock in Arcus Biosciences, Capricor Therapeutics, Orphazyme, Sundial Growers, or Citius Pharmaceuticals?
    Thinking about buying stock in Arcus Biosciences, Capricor Therapeutics, Orphazyme, Sundial Growers, or Citius Pharmaceuticals? PR Newswire
    26.06.18 - PR Newswire
    Arcus Biosciences and Infinity Pharmaceuticals Announce Clinical Collaboration to Evaluate Lead Programs in Triple-Combination Studies
    Arcus Biosciences and Infinity Pharmaceuticals Announce Clinical Collaboration to Evaluate Lead Programs in Triple-​Combination Studies - IPI-549 with AB928 and AB122 in Triple ...

    Newssuche

    Videos

    newspaper
    26.04.24 +10,71%
    Technical Trading: Gold Long freitags
    Gold Long Typ: Turbo Open End WKN: NG8DB8 Hebel: 27 Laufzeit: OpenEnd Einstieg: Market ... Mehr »